{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:43:34Z","timestamp":1792511014776,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T00:00:00Z","timestamp":1345161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T00:00:00Z","timestamp":1345161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Hyperuricemia is the greatest risk factor for gout and is caused by an overproduction and\/or inefficient renal clearance of urate. The fractional renal clearance of urate (FCU, renal clearance of urate\/renal clearance of creatinine) has been proposed as a tool to identify subjects who manifest inefficient clearance of urate. The aim of the present studies was to validate the measurement of FCU by using spot-urine samples as a reliable indicator of the efficiency of the kidney to remove urate and to explore its distribution in healthy subjects and gouty patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Timed (spot, 2-hour, 4-hour, 6-hour, 12-hour, and 24-hour) urine collections were used to derive FCU in 12 healthy subjects. FCUs from spot-urine samples were then determined in 13 healthy subjects twice a day, repeated on 3 nonconsecutive days. The effect of allopurinol, probenecid, and the combination on FCU was explored in 11 healthy subjects. FCU was determined in 36 patients with gout being treated with allopurinol. The distribution of FCU was examined in 118 healthy subjects and compared with that from the 36 patients with gout.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>No substantive or statistically significant differences were observed between the FCUs derived from spot and 24-hour urine collections. Coefficients of variation (CVs) were both 28%. No significant variation in the spot FCU was obtained either within or between days, with mean intrasubject CV of 16.4%. FCU increased with probenecid (<jats:italic>P<\/jats:italic> &lt; 0.05), whereas allopurinol did not change the FCU in healthy or gouty subjects. FCUs of patients with gout were lower than the FCUs of healthy subjects (4.8% versus 6.9%; <jats:italic>P<\/jats:italic> &lt; 0.0001).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>The present studies indicate that the spot-FCU is a convenient, valid, and reliable indicator of the efficiency of the kidney in removing urate from the blood and thus from tissues. Spot-FCU determinations may provide useful correlates in studies investigating molecular mechanisms underpinning the observed range of efficiencies of the kidneys in clearing urate from the blood.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Trial Registration<\/jats:title>\n                        <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.anzctr.org.au\/ACTRN12611000743965.aspx\">ACTRN12611000743965<\/jats:ext-link><\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar4020","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T12:14:26Z","timestamp":1345205666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients"],"prefix":"10.1186","volume":"14","author":[{"given":"Diluk RW","family":"Kannangara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena N","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen L","family":"Indraratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie L","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry G","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Portek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard O","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,17]]},"reference":[{"key":"3761_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar3199","volume":"12","author":"E Roddy","year":"2010","unstructured":"Roddy E, Doherty M: Epidemiology of gout. Arthritis Res Ther. 2010, 12: 223-10.1186\/ar3199.","journal-title":"Arthritis Res Ther"},{"key":"3761_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ijcard.2007.11.094","volume":"125","author":"AM Strasak","year":"2008","unstructured":"Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H: Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol. 2008, 125: 232-239. 10.1016\/j.ijcard.2007.11.094.","journal-title":"Int J Cardiol"},{"key":"3761_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Kim SY, LaValley M, Choi HK: Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011, 63: 102-110. 10.1002\/acr.20344.","journal-title":"Arthritis Care Res"},{"key":"3761_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM: Pathogenesis of gout. Ann Intern Med. 2005, 143: 499-516.","journal-title":"Ann Intern Med"},{"key":"3761_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/art.1780080429","volume":"8","author":"LB Sorensen","year":"1965","unstructured":"Sorensen LB: Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum. 1965, 8: 694-706. 10.1002\/art.1780080429.","journal-title":"Arthritis Rheum"},{"key":"3761_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/art.11376","volume":"49","author":"PA Simkin","year":"2003","unstructured":"Simkin PA: New standards for uric acid excretion and evidence for an inducible transporter. Arthritis Rheum. 2003, 49: 735-736. 10.1002\/art.11376.","journal-title":"Arthritis Rheum"},{"key":"3761_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2362.1980.tb00035.x","volume":"10","author":"F Lang","year":"1980","unstructured":"Lang F, Greger R, Oberleithner H, Griss E, Lang K, Pastner D, Dittrich P, Deetjen P: Renal handling of urate in healthy man in hyperuricaemia and renal insufficiency: circadian fluctuation, effect of water diuresis and of uricosuric agents. Eur J Clin Invest. 1980, 10: 285-292. 10.1111\/j.1365-2362.1980.tb00035.x.","journal-title":"Eur J Clin Invest"},{"key":"3761_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/157339711795305059","volume":"7","author":"N Anzai","year":"2011","unstructured":"Anzai N, Jutabha P, Kimura T, Fukutomi T: Urate transport: regulators of serum urate levels in humans. Curr Rheumatol Rev. 2011, 7: 123-131. 10.2174\/157339711795305059.","journal-title":"Curr Rheumatol Rev"},{"key":"3761_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/ard.51.3.375","volume":"51","author":"BT Emmerson","year":"1992","unstructured":"Emmerson BT, Nagel SL, Duffy DL, Martin NG: Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis. 1992, 51: 375-377. 10.1136\/ard.51.3.375.","journal-title":"Ann Rheum Dis"},{"key":"3761_CR10","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","volume":"372","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, Witteman JC, Coresh J, Fox CS: Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008, 372: 1953-1961. 10.1016\/S0140-6736(08)61343-4.","journal-title":"Lancet"},{"key":"3761_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ng.106","volume":"40","author":"V Vitart","year":"2008","unstructured":"Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, Knott SA, Kolcic I, Polasek O, Graessler J, Wilson JF, Marinaki A, Riches PL, Shu X, Janicijevic B, Smolej-Narancic N, Gorgoni B, Morgan J, Campbell S, Biloglav Z, Barac-Lauc L, Pericic M, Klaric IM, Zgaga L, Skaric-Juric T, Wild SH, Richardson WA, Hohenstein P, Kimber CH, Tenesa A, et al: SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008, 40: 437-442. 10.1038\/ng.106.","journal-title":"Nat Genet"},{"key":"3761_CR12","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.0901249106","volume":"106","author":"OM Woodward","year":"2009","unstructured":"Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M: Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA. 2009, 106: 10338-10342. 10.1073\/pnas.0901249106.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3761_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/ar3191","volume":"12","author":"PL Indraratna","year":"2010","unstructured":"Indraratna PL, Stocker SL, Williams KM, Graham GG, Jones G, Day RO: A proposal for identifying the low renal uric acid clearance phenotype. Arthritis Res Ther. 2010, 12: 149-10.1186\/ar3191.","journal-title":"Arthritis Res Ther"},{"key":"3761_CR14","first-page":"1207","volume":"28","author":"PA Simkin","year":"2001","unstructured":"Simkin PA: When, why, and how should we quantify the excretion rate of urinary uric acid?. J Rheumatol. 2001, 28: 1207-1210.","journal-title":"J Rheumatol"},{"key":"3761_CR15","doi-asserted-by":"publisher","first-page":"625.e1","DOI":"10.1016\/j.ajog.2008.06.009","volume":"199","author":"AM Cote","year":"2008","unstructured":"Cote AM, Firoz T, Mattman A, Lam EM, von Dadelszen P, Magee LA: The 24-hour urine collection: gold standard or historical practice?. Am J Obstet Gynecol. 2008, 199: 625.e1-625.e6. 10.1016\/j.ajog.2008.06.009.","journal-title":"Am J Obstet Gynecol"},{"key":"3761_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.metabol.2011.08.005","volume":"61","author":"JG Puig","year":"2012","unstructured":"Puig JG, Torres RJ, de Miguel E, Sanchez A, Bailen R, Banegas JR: Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders. Metabolism. 2012, 61: 512-518. 10.1016\/j.metabol.2011.08.005.","journal-title":"Metabolism"},{"key":"3761_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000184368","volume":"46","author":"A Garyfallos","year":"1987","unstructured":"Garyfallos A, Magoula I, Tsapas G: Evaluation of the renal mechanisms for urate homeostasis in uremic patients by probenecid and pyrazinamide test. Nephron. 1987, 46: 273-280. 10.1159\/000184368.","journal-title":"Nephron"},{"key":"3761_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00003088-200847020-00004","volume":"47","author":"SL Stocker","year":"2008","unstructured":"Stocker SL, Williams KM, McLachlan AJ, Graham GG, Day RO: Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects. Clin Pharmacokinet. 2008, 47: 111-118. 10.2165\/00003088-200847020-00004.","journal-title":"Clin Pharmacokinet"},{"key":"3761_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.7326\/0003-4819-73-3-359","volume":"73","author":"RE Rieselbach","year":"1970","unstructured":"Rieselbach RE, Sorensen LB, Shelp WD, Steele TH: Diminished renal urate secretion per nephron as a basis for primary gout. Ann Intern Med. 1970, 73: 359-366.","journal-title":"Ann Intern Med"},{"key":"3761_CR20","first-page":"1937","volume":"29","author":"T Yamamoto","year":"2002","unstructured":"Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ka T, Fukuchi M, Hada T: A simple method of selecting gout patients for treatment with uricosuric agents, using spot urine and blood samples. J Rheumatol. 2002, 29: 1937-1941.","journal-title":"J Rheumatol"},{"key":"3761_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/ard.57.9.545","volume":"57","author":"F Perez-Ruiz","year":"1998","unstructured":"Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, Herrero-Beites A, Garcia-Erauskin G, Ruiz-Lucea E: Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia: a pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis. 1998, 57: 545-549. 10.1136\/ard.57.9.545.","journal-title":"Ann Rheum Dis"},{"key":"3761_CR22","first-page":"1306","volume":"28","author":"Y Moriwaki","year":"2001","unstructured":"Moriwaki Y, Yamamoto T, Takahashi S, Yamakita J, Tsutsumi Z, Hada T: Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout. J Rheumatol. 2001, 28: 1306-1310.","journal-title":"J Rheumatol"},{"key":"3761_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0002-9343(74)90847-X","volume":"57","author":"MA Manuel","year":"1974","unstructured":"Manuel MA, Steele TH: Changes in renal urate handling after prolonged thiazide treatment. Am J Med. 1974, 57: 741-746. 10.1016\/0002-9343(74)90847-X.","journal-title":"Am J Med"},{"key":"3761_CR24","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1172\/JCI104560","volume":"41","author":"JE Seegmiller","year":"1962","unstructured":"Seegmiller JE, Grayzel AI, Howell RR, Plato C: The renal excretion of uric acid in gout. J Clin Invest. 1962, 41: 1094-1098. 10.1172\/JCI104560.","journal-title":"J Clin Invest"},{"key":"3761_CR25","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1172\/JCI104653","volume":"41","author":"W Lathem","year":"1962","unstructured":"Lathem W, Rodnan GP: Impairment of uric acid excretion in gout. J Clin Invest. 1962, 41: 1955-1963. 10.1172\/JCI104653.","journal-title":"J Clin Invest"},{"key":"3761_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-4615-2584-4_23","volume":"370","author":"CP Quaratino","year":"1994","unstructured":"Quaratino CP, Di Sciascio N, Rucci C, Ciaglia P, Giacomello A: The normal range of serum urate levels and of fractional urate excretion. Adv Exp Med Biol. 1994, 370: 91-93.","journal-title":"Adv Exp Med Biol"},{"key":"3761_CR27","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/rheumatology\/33.10.932","volume":"33","author":"HA Simmonds","year":"1994","unstructured":"Simmonds HA, McBride MB, Hatfield PJ, Graham R, McCaskey J, Jackson M: Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol. 1994, 33: 932-937. 10.1093\/rheumatology\/33.10.932.","journal-title":"Br J Rheumatol"},{"key":"3761_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/art.10792","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Erauskin GG, Ruibal A, Herrero-Beites AM: Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum. 2002, 47: 610-613. 10.1002\/art.10792.","journal-title":"Arthritis Rheum"},{"key":"3761_CR29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/clinchem\/26.2.227","volume":"26","author":"P Fossati","year":"1980","unstructured":"Fossati P, Prencipe L, Berti G: Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid\/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem. 1980, 26: 227-231.","journal-title":"Clin Chem"},{"key":"3761_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1214\/aoms\/1177729885","volume":"21","author":"FE Grubbs","year":"1950","unstructured":"Grubbs FE: Sample criteria for testing outlying observations. Ann Math Stat. 1950, 21: 27-58. 10.1214\/aoms\/1177729885.","journal-title":"Ann Math Stat"},{"key":"3761_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1440-1797.2010.01368.x","volume":"16","author":"HJ Shin","year":"2011","unstructured":"Shin HJ, Takeda M, Enomoto A, Fujimura M, Miyazaki H, Anzai N, Endou H: Interactions of urate transporter URAT1 in human kidney with uricosuric drugs. Nephrology. 2011, 16: 156-162. 10.1111\/j.1440-1797.2010.01368.x.","journal-title":"Nephrology"},{"key":"3761_CR32","first-page":"195","volume":"10","author":"EW Vahlensieck","year":"1982","unstructured":"Vahlensieck EW, Bach D, Hesse A: Circadian rhythm of lithogenic substances in the urine. Urol Res. 1982, 10: 195-203.","journal-title":"Urol Res"},{"key":"3761_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365517109080181","volume":"27","author":"A Pasternack","year":"1971","unstructured":"Pasternack A, Kuhlback B: Diurnal variations of serum and urine creatine and creatinine. Scand J Clin Lab Invest. 1971, 27: 1-7. 10.3109\/00365517109080181.","journal-title":"Scand J Clin Lab Invest"},{"key":"3761_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/ard.29.4.397","volume":"29","author":"JT Scott","year":"1970","unstructured":"Scott JT, Pollard AC: Uric acid excretion in the relatives of patients with gout. Ann Rheum Dis. 1970, 29: 397-400. 10.1136\/ard.29.4.397.","journal-title":"Ann Rheum Dis"},{"key":"3761_CR35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0140-6736(99)92381-4","volume":"354","author":"H Sumino","year":"1999","unstructured":"Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T: Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet. 1999, 354: 650-","journal-title":"Lancet"},{"key":"3761_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/bmj.1.5851.449","volume":"1","author":"A Nicholls","year":"1973","unstructured":"Nicholls A, Snaith ML, Scott JT: Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J. 1973, 1: 449-451. 10.1136\/bmj.1.5851.449.","journal-title":"Br Med J"},{"key":"3761_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-4615-2584-4_23","volume":"370","author":"CP Quaratino","year":"1994","unstructured":"Quaratino CP, Di Sciascio N, Rucci C, Ciaglia P, Giacomello A: The normal range of serum urate levels and of fractional urate excretion. Adv Exp Med Biol. 1994, 370: 91-93.","journal-title":"Adv Exp Med Biol"},{"key":"3761_CR38","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1172\/JCI103966","volume":"38","author":"CA Nugent","year":"1959","unstructured":"Nugent CA, Tyler FH: The renal excretion of uric acid in patients with gout and in nongouty subjects. J Clin Invest. 1959, 38: 1890-1898. 10.1172\/JCI103966.","journal-title":"J Clin Invest"},{"key":"3761_CR39","first-page":"382","volume":"21","author":"C Fontenaille","year":"1974","unstructured":"Fontenaille C, Guiheneuc P, Heron B, Prost A, Lucas J: Renal excretion of urate in normal and gouty subjects at high, normal and low plasma urate levels. Biomedicine. 1974, 21: 382-385.","journal-title":"Biomedicine"},{"key":"3761_CR40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1159\/000168174","volume":"10","author":"K Fushimi","year":"1990","unstructured":"Fushimi K, Shichiri M, Marumo F: Decreased fractional excretion of urate as an indicator of prerenal azotemia. Am J Nephrol. 1990, 10: 489-494. 10.1159\/000168174.","journal-title":"Am J Nephrol"},{"key":"3761_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00861588","volume":"7","author":"JS Cameron","year":"1993","unstructured":"Cameron JS, Moro F, Simmonds HA: Gout, uric acid and purine metabolism in paediatric nephrology. Pediatr Nephrol. 1993, 7: 105-118. 10.1007\/BF00861588.","journal-title":"Pediatr Nephrol"},{"key":"3761_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s004670050466","volume":"12","author":"MB McBride","year":"1998","unstructured":"McBride MB, Rigden S, Haycock GB, Dalton N, Van't Hoff W, Rees L, Raman GV, Moro F, Ogg CS, Cameron JS, Simmonds HA: Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children. Pediatr Nephrol. 1998, 12: 357-364. 10.1007\/s004670050466.","journal-title":"Pediatr Nephrol"},{"key":"3761_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/00005392-200102000-00006","volume":"165","author":"CY Pak","year":"2001","unstructured":"Pak CY, Peterson R, Poindexter JR: Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol. 2001, 165: 378-381. 10.1097\/00005392-200102000-00006.","journal-title":"J Urol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4020\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:36:46Z","timestamp":1728383806000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,17]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,8]]}},"alternative-id":["3761"],"URL":"https:\/\/doi.org\/10.1186\/ar4020","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,17]]},"assertion":[{"value":"10 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R189"}}